19.11.2015 • NewsDede WillamsLife SciencesMerck

Sigma-Aldrich now Part of Merck KGaA

With the integration of the US fine chemicals producer, Merck will have some...
With the integration of the US fine chemicals producer, Merck will have some 50,000 employees at 72 production sites in 67 countries and pro forma sales of its life sciences segment of €4.6 billion, based on 2014 figures. Consolidated group sales are expected to total €12.6-12.8 billion for full-year 2015.

Germany’s Merck KGaA has now completed its $17 billion acquisition of Sigma-Aldrich after clearing all anti-trust hurdles. With the integration of the US fine chemicals producer, Merck will have some 50,000 employees at 72 production sites in 67 countries and pro forma sales of its life sciences segment of €4.6 billion, based on 2014 figures. Consolidated group sales are expected to total €12.6-12.8 billion for full-year 2015.

Over the past decade, the German company that combines life sciences with pharmaceuticals chemicals has made transformational acquisitions and divestments worth a composite sum of €38 billion.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read